观察硫酸依替米星治疗风湿免疫性疾病合并各类型感染者的临床效果。将患者随机分两组 ,治疗组应用硫酸依替米星 ,对照组应用阿米卡星 ,每天 0 .2 g,10 d为一疗程。结果治疗组无论在临床疗效还是细菌学评价上均优于对照组 ,而不良反应少于对照组 ,差异显著。结论 :硫酸依替米星在治疗风湿免疫性疾病合并各类型感染上是一种疗效高、安全性好的新抗生素。 To observe the clinical efficacy of etimicin sulfate in the treatment of rheumatoid autoimmune diseases complicated with various types of infections. The patients were randomly divided into two groups, the treatment group application of etimicin sulfate, the control group application of amikacin, 0.2 g daily, 10 d for a course of treatment. Results The treatment group was superior to the control group both in clinical efficacy and bacteriological evaluation, while the adverse reactions were less than those in the control group, the difference was significant. Conclusion: Etimicin sulfate is a new antibiotic with high efficacy and safety in the treatment of various types of infections associated with rheumatic autoimmune diseases.